Resistant starch, β-glucan, and inulin
This 2021 paper reported results of two related human clinical trials: “Lean and prediabetic overweight/obese men were included in two randomized crossover studies. In one study, participants received supplements of either long-chain inulin+resistant starch (INU+RS), INU or maltodextrin (placebo, PLA) the day prior to a clinical investigation day. The second trial studied beta glucan+RS (BG+RS) … Continue reading Resistant starch, β-glucan, and inulin